Skip to content

Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity.

Robert V. House, P T Thomas, Hemendra N. Bhargava

Pharmacology June 1, 1995 DOI: 10.1159/000139317 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics In vitro study Peer reviewed
Interventions Ibogaine harmaline
Dose 10-100 µmol/L
Topics Ibogaine
Citations 12
Key points Ibogaine and harmaline cause dose-related suppression of T-cell, B-cell, and natural killer-cell function but not macrophage function at high concentrations.

Abstract

The immunomodulatory potential of the indole alkaloids ibogaine and harmaline was examined in a panel of in vitro immune function assays. These assays were chosen to assess T-cell regulatory and effector function, B-cell function, macrophage function, and natural killer-cell function. The in vitro exposure to either ibogaine or harmaline resulted in a dose-related suppression of all immune functions examined except macrophage function. This suppression was noted at various concentrations in different assays, but was generally only associated with high concentrations (10-100 mumol/l).

Comparable studies

Other preclinical and animal studies on ibogaine, most cited first.

Citations in the library

Explore topics